Mutant KRAS peptide vaccine with dual checkpoint blockade in metastatic colorectal cancer: a phase I trialHejia Wang, Neeha Zaidi, Amanda L. Huff et al.|Nature Communications|2026Cited by 1
First-in-human testing of a mutant KRAS vaccine for pancreatic cancer interception in high-risk cohortsSaurav D. Haldar, Neeha Zaidi, Maureen Berg et al.|Cancer Discovery|2026Cited by 1